Synergistic bone regeneration through sequential dual-drug delivery

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedics

Background:

• Global aging population increases incidence of osteoporosis and bone fractures.
• Current bone scaffolds face challenges with uncontrolled drug release, leading to adverse effects.
• Need for advanced therapeutic scaffolds for effective bone regeneration.

Purpose of the Study:

• To synthesize a collagen-hydroxyapatite scaffold (COHAS) for sequential delivery of BMP-2 and OPG-Fc.
• To investigate the synergistic effect of sequential BMP-2 and OPG-Fc release on bone formation.
• To evaluate the in vitro and in vivo efficacy of the drug-loaded COHAS.

Main Methods:

• Synthesis of COHAS matrix incorporating BMP-2 and PLGA microspheres loaded with OPG-Fc.
• Controlled release study demonstrating retarded OPG-Fc release compared to BMP-2.
• In vitro assessment of cell viability and osteogenic properties.
• In vivo implantation in an 8 mm calvarial defect rat model.

Main Results:

• COHAS demonstrated controlled sequential release of BMP-2 and OPG-Fc.
• In vitro studies showed excellent cell viability and enhanced osteogenic properties.
• In vivo implantation resulted in significant new bone formation and good biocompatibility.

Conclusions:

• The developed COHAS facilitates sequential delivery of multiple therapeutic agents for bone regeneration.
• Sequential BMP-2 and OPG-Fc delivery shows synergistic potential by activating osteoblasts and deactivating osteoclasts.
• This cell-free scaffold system offers a promising therapeutic strategy for bone defect repair.